Publicaciones en colaboración con investigadores/as de Albert Einstein Hospital (3)

2021

  1. Efficacy and safety of Sandoz biosimilar rituximab for active rheumatoid arthritis: 52-week results from the randomized controlled ASSIST-RA trial

    Rheumatology (United Kingdom), Vol. 60, Núm. 1, pp. 256-262

2017

  1. A randomised, double-blind trial to demonstrate bioequivalence of GP2013 and reference rituximab combined with methotrexate in patients with active rheumatoid arthritis

    Annals of the Rheumatic Diseases, Vol. 76, Núm. 9, pp. 1598-1602

2016

  1. Therapy: The NICE position on indications for biologics and biosimilars

    Nature Reviews Rheumatology